1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Cold feet...

Discussion in 'ERMI' started by Anonymous, Apr 8, 2014 at 5:31 PM.

  1. Anonymous

    Anonymous Guest

    Keep wanting to kickoff this Cafe welcome party, but I always get cold feet. Can anyone help?
     
  2. Anonymous

    Anonymous Guest

    get a new job
     
  3. Anonymous

    Anonymous Guest

    Company is worthless….
     
  4. I agree. This company sucks. I interviewed with them a few months ago and didn't even bother closing. I asked the RM a question and as he proceeded to answer I packed up my things and said "I'm sorry but I have to leave. I have another interview to attend". Seriously...who's buying the "Flexionator" or "The Extensionater"? This company is so 1980. I was waiting to be greeted by Burt Reynolds! "The Flexionator" LMAO...GTFOH!